logo

For the Inventor, By the Inventor

Allschwil, Switzerland

Hans Stettler

This inventor holds 8 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Novartis Ag, Sandoz Gmbh. Active years: 1983-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Stettler. Retrieved from https://idiyas.com/inventor/hans-stettler-u44rau7l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5


Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Basel, CH (1983 - 1984)
  • Allschwil, CH (2013 - 2017)

Company Filing History:

goldMedal5 out of 3,978 
 
Novartis Ag
 patents
silverMedal3 out of 1,603 
 
Sandoz Gmbh
 patents

Years Active: 1983-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 9637468 - Process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine (2017-05-02),
2. 9493512 - Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates (2016-11-15),
3. 9278997 - Processes for the manufacture of macrocyclic depsipeptides and new intermediates (2016-03-08),
4. 9067978 - Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates (2015-06-30),
5. 8614289 - Processes for the manufacture of macrocyclic depsipeptides and new intermediates (2013-12-24),
6. 4465516 - Asymmetrical diesters of ortho-phosphoric acid useful as corrosion (1984-08-14),
7. 4389259 - Asymmetrical diesters of orthophosphoric acid useful as corrosion (1983-06-21),
8. 4388205 - Phosphate-free cleaning compositions (1983-06-14),

Title: The Innovative Contributions of Hans Stettler

Introduction

Hans Stettler is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of chemical manufacturing, holding a total of 8 patents. His work focuses on improving processes for synthesizing complex compounds, which has implications in various industries.

Latest Patents

Stettler's latest patents include a process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine. This invention discloses improved methods for producing this compound, its monohydrochloride salt, and related intermediates. Another significant patent involves solution phase processes for the manufacture of macrocyclic depsipeptides, detailing a method for the chemical synthesis of these compounds and introducing new intermediates.

Career Highlights

Throughout his career, Hans Stettler has worked with prominent companies such as Novartis AG and Sandoz GmbH. His experience in these organizations has allowed him to develop and refine his innovative approaches to chemical manufacturing.

Collaborations

Stettler has collaborated with notable professionals in his field, including Murat Acemoglu and Heribert Hellstern. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Hans Stettler's contributions to the field of chemical manufacturing through his patents and collaborations highlight his innovative spirit and dedication to advancing technology. His work continues to influence the industry and pave the way for future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…